Image-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging

Abstract: We summarise here the information to be provided to women and referring physicians about percutaneous breast biopsy and lesion localisation under imaging guidance. After explaining why a preoperative diagnosis with a percutaneous biopsy is preferred to surgical biopsy, we illustrate the criteria used by radiologists for choosing the most appropriate combination of device type for sampling and imaging technique for guidance. Then, we describe the commonly used devices, from fine-needle sampling to tissue biopsy with larger needles, namely core needle biopsy and vacuum-assisted biopsy, and how mammography, digital breast tomosynthesis, ultrasound, or magnetic resonance imaging work for targeting the lesion for sampling or localisation. The differences among the techniques available for localisation (carbon marking, metallic wire, radiotracer injection, radioactive seed, and magnetic seed localisation) are illustrated. Type and rate of possible complications are described and the issue of concomitant antiplatelet or anticoagulant therapy is also addressed. The importance of pathological-radiological correlation is highlighted: when evaluating the results of any needle sampling, the radiologist must check the concordance between the cytology/pathology report of the sample and the radiological appearance of the biopsied lesion. We recommend that special attention is paid to a proper and tactful approach when communicating to the woman the need for tissue sampling as well as the possibility of cancer diagnosis, repeat tissue sampling, and or even surgery when tissue sampling shows a lesion with uncertain malignant potential (also referred to as “high-risk” or B3 lesions). Finally, seven frequently asked questions are answered

A Comparative study of Palpatory Versus Image Guided Core Needle Biopsy in Breast Masses in Government Rajaji Hospital, Madurai

OBJECTIVES: Biopsy of palpable breast masses can be performed manually by palpation guidance or under imaging guidance. We conducted this prospective study to verify the superiority and determine the size of beneficial effect of image guided biopsy over palpation guided biopsy. METHODOLOGY: This is a prospective study comprising 60 patients with breast masses over a period from September 2018 to September 2019. In this present study, the clinical material consists of adult female patients attending out-patient department with palpable breast masses on examination and on radiological investigation usg showing BIRADS 4, 5 and patient with BIRADS 3 high risk, difficult to follow or patient anxious are included in the study. During this period 60 female patient agreed to participate in study and gave informed consent.21 patients reported as Birads IV,26 patients reported as Birads V,13 patients with Birads III who satisfy inclusion criteria are taken to study. Patients are randomised into two arms 30 each to image guided and palpatory guided biopsy with ratio of 1:1. RESULTS: Malignancy was found in 24 of 30 women in palpation guided biopsy arm and 20 of 30 women in image guided biopsy arm. Palpation guided biopsy had sensitivity, and negative predictive value (NPV) of 48, 100, 100, 27.8 per cent, respectively, for diagnosing breast cancer. Palpation guided biopsy group had a high repeat biopsy rate. Image guided biopsy had 85 per cent sensitivity and 100 per cent specificity. CONCLUSION: Our results showed that in palpable breast masses, image guided biopsy was superior to palpation guided biopsy in terms of sensitivity, false negative rate and repeat biopsy rates

Endorectal Digital Prostate Tomosynthesis

Several areas of prostate cancer (PCa) management, such as imaging permanent brachytherapy implants or small, aggressive lesions, benefit from high image resolution. Current PCa imaging methods can have inadequate resolution for imaging these areas. Endorectal digital prostate tomosynthesis (endoDPT), an imaging method that combines an external x-ray source and an endorectal x-ray sensor, can produce three-dimensional images of the prostate region that have high image resolution compared to typical methods. This high resolution may improve PCa management and increase positive outcomes in affected men. This dissertation presents the initial development of endoDPT, including system design, image quality assessment, and examples of possible applications to prostate imaging. Experiments using computational phantoms, physical phantoms, and canine prostate specimens were conducted. Initial system design was performed computationally and three methods of endoDPT image reconstruction were developed: shift and add (SAA), backprojection (BP), and filtered BP (FBP). A physical system was developed using an XDR intraoral x-ray sensor and a GE radiography unit. The resolution and radiation dose of endoDPT were measured and compared to a GE CT scanner. Canine prostate specimens that approximated clinical cases of PCa management were imaged and compared using endoDPT, the above CT scanner, and a GE MRI scanner. This study found that the resolution of endoDPT was significantly higher than CT. The radiation dose of endoDPT was significantly lower than CT in the regions of the phantom that were not in the endoDPT field of view (FoV). Inside the endoDPT FoV, the radiation dose ranged from significantly less than to significantly greater than CT. The endoDPT images of the canine prostate specimens demonstrated qualitative improvements in resolution compared to CT and MRI, but endoDPT had difficulty in visualizing larger structures, such as the prostate border. Overall, this study has demonstrated endoDPT has high image resolution compared to typical methods of PCa imaging. Future work will be focused on development of a prototype system that improves scanning efficiency that can be used to optimize endoDPT and perform pre-clinical studies

European breast surgical oncology certification theoretical and practical knowledge curriculum 2020

The Breast Surgery theoretical and practical knowledge curriculum comprehensively describes the knowledge and skills expected of a fully trained surgeon practicing in the European Union and European Economic Area (EEA). It forms part of a range of factors that contribute to the delivery of high quality cancer care. It has been developed by a panel of experts from across Europe and has been validated by professional breast surgery societies in Europe. The curriculum maps closely to the syllabus of the Union of European Medical Specialists (UEMS) Breast Surgery Exam, the UK FRCS (breast specialist interest) curriculum and other professional standards across Europe and globally (USA Society of Surgical Oncology, SSO). It is envisioned that this will serve as the basis for breast surgery training, examination and accreditation across Europe to harmonise and raise standards as breast surgery develops as a separate discipline from its parent specialties (general surgery, gynaecology, surgical oncology and plastic surgery). The curriculum is not static but will be revised and updated by the curriculum development group of the European Breast Surgical Oncology Certification group (BRESO) every 2 years

Development and Validation of Mechatronic Systems for Image-Guided Needle Interventions and Point-of-Care Breast Cancer Screening with Ultrasound (2D and 3D) and Positron Emission Mammography

The successful intervention of breast cancer relies on effective early detection and definitive diagnosis. While conventional screening mammography has substantially reduced breast cancer-related mortalities, substantial challenges persist in women with dense breasts. Additionally, complex interrelated risk factors and healthcare disparities contribute to breast cancer-related inequities, which restrict accessibility, impose cost constraints, and reduce inclusivity to high-quality healthcare. These limitations predominantly stem from the inadequate sensitivity and clinical utility of currently available approaches in increased-risk populations, including those with dense breasts, underserved and vulnerable populations. This PhD dissertation aims to describe the development and validation of alternative, cost-effective, robust, and high-resolution systems for point-of-care (POC) breast cancer screening and image-guided needle interventions. Specifically, 2D and 3D ultrasound (US) and positron emission mammography (PEM) were employed to improve detection, independent of breast density, in conjunction with mechatronic and automated approaches for accurate image acquisition and precise interventional workflow. First, a mechatronic guidance system for US-guided biopsy under high-resolution PEM localization was developed to improve spatial sampling of early-stage breast cancers. Validation and phantom studies showed accurate needle positioning and 3D spatial sampling under simulated PEM localization. Subsequently, a whole-breast spatially-tracked 3DUS system for point-of-care screening was developed, optimized, and validated within a clinically-relevant workspace and healthy volunteer studies. To improve robust image acquisition and adaptability to diverse patient populations, an alternative, cost-effective, portable, and patient-dedicated 3D automated breast (AB) US system for point-of-care screening was developed. Validation showed accurate geometric reconstruction, feasible clinical workflow, and proof-of-concept utility across healthy volunteers and acquisition conditions. Lastly, an orthogonal acquisition and 3D complementary breast (CB) US generation approach were described and experimentally validated to improve spatial resolution uniformity by recovering poor out-of-plane resolution. These systems developed and described throughout this dissertation show promise as alternative, cost-effective, robust, and high-resolution approaches for improving early detection and definitive diagnosis. Consequently, these contributions may advance breast cancer-related equities and improve outcomes in increased-risk populations and limited-resource settings

STATIONARY DIGITAL TOMOSYNTHESIS: IMPLEMENTATION, CHARACTERIZATION, AND IMAGE PROCESSING TECHNIQUES

The use of carbon nanotube cathodes for x-ray generation was pioneered and perfected by our team in the Applied Nanotechnology Laboratory at the University of North Carolina at Chapel Hill. Over the past decade, carbon nanotube (CNT) field emission x-ray source technology has matured and translated into multiple pre-clinical and clinical devices. One of the most prominent implementations of CNT x-ray technology is a limited angle tomography method called tomosynthesis, which is rapidly emerging in clinical radiography. The purpose of this project is two-fold, to develop and characterize to the latest iteration, stationary intraoral tomosynthesis, and develop a low-dose, effective scatter reduction technique for breast and chest tomosynthesis. The first portion of this project was to develop and evaluate a new quasi-3D imaging modality for dental imaging. My work consists of experiments which dictated the design parameters and subsequent system evaluation of the dedicated s-IOT clinical prototype system currently installed in the UNC Department of Oral and Maxillofacial Radiology clinic in the School of Dentistry. Experiments were performed in our lab to determine optimal source array geometry and system configuration. The system was fabricated by our commercial partner then housed in our research lab where I performed initial characterization and assisted with software development. After installation in the SOD, I performed additional system characterization, including source output validation, dosimetry, and quantification of resolution. The system components and software were refined through a rapid feedback loop with the engineers involved. Four pre-clinical imaging studies have been performed in collaboration with several dentists using phantoms, extracted teeth, and cadaveric dentition. I have generated an operating manual and trained four dental radiologists in the use of the s-IOT device. The system has now been vetted and is ready for patient use. The second portion of this project consists of hardware development and implementation of an image processing technique for scatter correction. The primary sampling scatter correction (PSSC) is a beam pass technique to measure the primary transmission through the patient and calculate the scatter profile for subtraction. Though developed for breast and chest tomosynthesis, utilization in mammography and chest radiography are also demonstrated in this project. This dissertation is composed of five chapters. Chapters one and two provide the basics of x-ray generation and a brief history of the evolution of carbon nanotube x-ray source technology in our lab at UNC. Chapter three focuses on stationary intraoral tomosynthesis. The first section provides background information on dental radiology and project motivation. Sections 3.2 and 3.3 detail my work in benchtop feasibility and optimization studies, as well as characterization and evaluation of the clinical prototype. Chapter four introduces scatter in imaging, providing motivation for my work on primary sampling scatter correction (PSSC) image processing method, detailed in chapter five.Doctor of Philosoph

Locoregional stage assessment in clinically node negative breast cancer: Clinical, imaging, pathologic, and statistical methods

The locoregional staging remains an essential part of prognostication in breast cancer. Tumour size and biology, together with the number of lymph node metastases, guide the planning of appropriate treatments. Accurate clinical, imaging, pathologic, and statistical staging is needed as the surgical staging diminishes. In this study, 743 clinically lymph node negative breast cancer patients treated in 2009‒2017 were evaluated. Clinopathological factors were investigated in association with the number of lymph node metastases, the use of preoperative imaging methods and the surgical treatment method. A nomogram was developed and tested to predict the number of lymph node metastases after sentinel lymph node positivity. Three previously published models were validated to confirm their feasibility in the current population to predict nodal stage pN2a or pN3a. Tumour size, biologic subtype and proliferation associated with higher numbers of lymph node metastases. To predict stage pN2a or pN3a, the machine learning algorithms identified tumour size, invasive ductal histology, multifocality, lymphovascular invasion, oestrogen receptor status and the number of positive sentinel lymph nodes as risk factors. The nomograms performed well with favourable discrimination. Clinopathological factors seemed to guide preoperative magnetic resonance imaging (MRI) prior to more extensive surgery. MRI estimated the increasing tumour size more accurately than mammography or ultrasound. According to this study, clinopathological factors, additional preoperative MRI and modern statistics can be utilized in breast cancer staging without extensive surgical interference. The importance of non-surgical investigations in staging is growing in the planning of surgical, systemic and radiation treatments. Thus, maintaining the impressive survival outcomes of clinically node negative breast cancer patients can be achieved.Kliinisesti imusolmukenegatiivisen rintasyövän paikallislevinneisyyden arvioiminen. Kliiniset, kuvantamisen, patologian alan ja tilastotieteen menetelmät Kasvaimen paikallinen levinneisyys on tärkeä rintasyövän ennustetekijä. Kasvaimen koko ja biologia sekä imusolmukemetastaasien lukumäärä ohjaavat syöpähoitojen suunnittelua. Levinneisyyden selvittelyssä tarvitaan huolellista kliinistä tutkimusta sekä tarkkoja kuvantamisen, patologian alan ja tilastotieteen menetelmiä, kun kirurginen levinneisyysluokittelu vähenee. Tutkimuksessa arvioitiin vuosina 2009‒2017 hoidettujen 743 kliinisesti imusolmukenegatiivisen suomalaisen potilaan tietoja. Työssä selvitettiin kliinispatologisten tekijöiden ja kainaloimusolmukemetastaasien lukumäärän, leikkausta edeltävien kuvantamistutkimusten sekä leikkausmenetelmien yhteyttä. Ennustemalli kehitettiin ja koekäytettiin positiivisen vartijaimusolmuketutkimuksen jälkeisen imusolmukemetastaasien määrän arvioimiseksi. Kolme aiemmin julkaistua mallia validoitiin, jotta niiden käyttökelpoisuus imusolmukeluokan pN2a tai pN3a ennustamisessa varmistuisi tässä aineistossa. Kasvainkoko, biologinen alatyyppi ja jakautumisnopeus olivat yhteydessä suurempaan imusolmukemetastaasien määrään. Koneoppimisalgoritmit määrittivät levinneisyysluokan pN2a tai pN3a ennustamiseksi tarvittaviksi tekijöiksi kasvainkoon, invasiivisen duktaalisen histologian, monipesäkkeisyyden, suoni-invaasion, estrogeenireseptoristatuksen sekä positiivisten vartijaimusolmukkeiden määrän. Ennustemallit toimivat aineistossa hyvin osoittaen suotuisaa erotuskykyä. Kliinispatologiset tekijät näyttivät ohjaavan magneettikuvauspäätöstä ennen laajaa kirurgista hoitoa. Magneettikuvaus oli tarkin kuvantamismenetelmä suurenevan kasvainkoon arvioinnissa. Tämän tutkimuksen perusteella kliinispatologiset tekijät, leikkausta edeltävä täydentävä magneettikuvaus ja nykyaikaiset tilastotieteen menetelmät voivat hyödyttää rintasyövän levinneisyysluokittelua ilman laajoja kirurgisia toimenpiteitä. Kajoamattomien tutkimusten asema levinneisyysluokittelussa on vahvistumassa kirurgisten, lääkkeellisten ja sädehoitojen suunnittelun yhteydessä. Tarkka levinneisyysluokittelu edesauttaa kliinisesti imusolmukenegatiivisten rintasyöpäpotilaiden erinomaista ennustetta